Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Qiiwi Games | QIIWI | Apr 23, 2024 | 1.80 | -1.64 |
QleanAir | QAIR | Apr 23, 2024 | 31.40 | -0.63 |
Qlife Holding | QLIFE | Apr 23, 2024 | 0.00 | -8.33 |
Qliro | QLIRO | Apr 23, 2024 | 23.00 | +0.66 |
Qlosr Group B | QLOSRB | Apr 23, 2024 | 1.50 | +1.70 |
Qlucore | QCORE | Apr 23, 2024 | 8.40 | 0.00 |
Quartiers Properties | QUART | Apr 23, 2024 | 11.10 | -1.77 |
Quartiers Properties PREF | QARTMTFPREF | Apr 23, 2024 | 10.20 | -1.92 |
Quartiers Properties Pref | QUARTPREF | Apr 23, 2024 | 10.20 | -1.92 |
QuiaPEG Pharmaceuticals Holding AB | QUIA | Apr 23, 2024 | 0.07 | +6.57 |
Quickbit | QBIT | Apr 23, 2024 | 1.95 | +2.37 |
Railcare Group | RAIL | Apr 23, 2024 | 27.40 | 0.00 |
Railway Metrics and Dynamics Sweden AB | RMDX | Apr 23, 2024 | 2.26 | 0.00 |
Raketech | RAKE | Apr 23, 2024 | 13.34 | -0.74 |
Rana Gruber ASA | RANAO | Apr 23, 2024 | 80.50 | +0.50 |
RanLOS | RLOSB | Apr 23, 2024 | 7.04 | -2.22 |
Ranplan Group | RPLAN | Apr 23, 2024 | 1.06 | 0.00 |
Ratos A | RATOA | Apr 23, 2024 | 37.40 | +3.89 |
Ratos B | RATOB | Apr 23, 2024 | 35.92 | +3.46 |
RaySearch Laboratories B | RAYB | Apr 23, 2024 | 118.80 | +1.54 |
Raytelligence | RAYTL | Apr 23, 2024 | 0.00 | -25.00 |
Readly International | READ | Apr 23, 2024 | 14.60 | 0.00 |
Real Fastigheter AB | REAL | Apr 23, 2024 | 8.48 | 0.00 |
RealFiction | REALFI | Apr 23, 2024 | 14.14 | +2.17 |
Recyctec B | RECYB | Apr 23, 2024 | 0.96 | +13.81 |
Rederi Gotland AB | GOTLA | Apr 23, 2024 | 2 040.00 | 0.00 |
Rederi Gotland AB. ser. B | GOTLB | Apr 23, 2024 | 2 040.00 | 0.00 |
Redsense Medical | REDS | Apr 23, 2024 | 6.10 | +2.01 |
Redwood Pharma | REDW | Apr 23, 2024 | 1.14 | +1.79 |
Refine Group | REFINE | Apr 23, 2024 | 1.91 | +0.26 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.